132 related articles for article (PubMed ID: 19185418)
1. Low molecular weight hyaluronan inhibits colorectal carcinoma growth by decreasing tumor cell proliferation and stimulating immune response.
Alaniz L; Rizzo M; Malvicini M; Jaunarena J; Avella D; Atorrasagasti C; Aquino JB; Garcia M; Matar P; Silva M; Mazzolini G
Cancer Lett; 2009 Jun; 278(1):9-16. PubMed ID: 19185418
[TBL] [Abstract][Full Text] [Related]
2. Low molecular weight hyaluronan preconditioning of tumor-pulsed dendritic cells increases their migratory ability and induces immunity against murine colorectal carcinoma.
Alaniz L; Rizzo M; Garcia MG; Piccioni F; Aquino JB; Malvicini M; Atorrasagasti C; Bayo J; Echeverria I; Sarobe P; Mazzolini G
Cancer Immunol Immunother; 2011 Oct; 60(10):1383-95. PubMed ID: 21638126
[TBL] [Abstract][Full Text] [Related]
3. High-molecular-weight hyaluronan inhibits macrophage proliferation and cytokine release in the early wound of a preclinical postlaminectomy rat model.
Schimizzi AL; Massie JB; Murphy M; Perry A; Kim CW; Garfin SR; Akeson WH
Spine J; 2006; 6(5):550-6. PubMed ID: 16934726
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan-coated nanoparticles: the influence of the molecular weight on CD44-hyaluronan interactions and on the immune response.
Mizrahy S; Raz SR; Hasgaard M; Liu H; Soffer-Tsur N; Cohen K; Dvash R; Landsman-Milo D; Bremer MG; Moghimi SM; Peer D
J Control Release; 2011 Dec; 156(2):231-8. PubMed ID: 21745506
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin inhibits hepatectomy-induced stimulation of metastatic tumor growth by reduction of angiogenesis, microvascular blood perfusion, and tumor cell proliferation.
Rupertus K; Dahlem C; Menger MD; Schilling MK; Kollmar O
Ann Surg Oncol; 2009 Sep; 16(9):2629-37. PubMed ID: 19551445
[TBL] [Abstract][Full Text] [Related]
6. Rofecoxib has different effects on chemokine production in colorectal cancer cells and tumor immune splenocytes.
Walmesley AJ; Zweiri J; Christmas SE; Watson AJ
J Immunother; 2007 Sep; 30(6):614-23. PubMed ID: 17667525
[TBL] [Abstract][Full Text] [Related]
7. Tumor-educated CD11bhighIalow regulatory dendritic cells suppress T cell response through arginase I.
Liu Q; Zhang C; Sun A; Zheng Y; Wang L; Cao X
J Immunol; 2009 May; 182(10):6207-16. PubMed ID: 19414774
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of fatty acid synthase expression in colorectal cancers in Middle Eastern patients and its potential role as a therapeutic target.
Uddin S; Hussain AR; Ahmed M; Abubaker J; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Bavi P; Al-Kuraya KS
Am J Gastroenterol; 2009 Jul; 104(7):1790-801. PubMed ID: 19491830
[TBL] [Abstract][Full Text] [Related]
9. Low molecular weight hyaluronan-pulsed human dendritic cells showed increased migration capacity and induced resistance to tumor chemoattraction.
Rizzo M; Bayo J; Piccioni F; Malvicini M; Fiore E; Peixoto E; García MG; Aquino JB; Gonzalez Campaña A; Podestá G; Terres M; Andriani O; Alaniz L; Mazzolini G
PLoS One; 2014; 9(9):e107944. PubMed ID: 25238610
[TBL] [Abstract][Full Text] [Related]
10. PNAS-4, a novel pro-apoptotic gene, can potentiate antineoplastic effects of cisplatin.
Yuan Z; Yan F; Wang YS; Liu HY; Gou LT; Zhao XY; Lai ST; Deng HX; Li J; Ding ZY; Xiong SQ; Kan B; Mao YQ; Chen LJ; Wei YQ; Zhao X
Cancer Chemother Pharmacol; 2009 Dec; 65(1):13-25. PubMed ID: 19387645
[TBL] [Abstract][Full Text] [Related]
11. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid of high molecular weight inhibits proliferation and induces cell death in U937 macrophage cells.
Sheehan KM; DeLott LB; West RA; Bonnema JD; DeHeer DH
Life Sci; 2004 Nov; 75(26):3087-102. PubMed ID: 15488890
[TBL] [Abstract][Full Text] [Related]
13. Corneal protection with high-molecular-weight hyaluronan against in vitro and in vivo sodium lauryl sulfate-induced toxic effects.
Pauloin T; Dutot M; Liang H; Chavinier E; Warnet JM; Rat P
Cornea; 2009 Oct; 28(9):1032-41. PubMed ID: 19724206
[TBL] [Abstract][Full Text] [Related]
14. Targeting hyaluronan interactions in malignant gliomas and their drug-resistant multipotent progenitors.
Gilg AG; Tye SL; Tolliver LB; Wheeler WG; Visconti RP; Duncan JD; Kostova FV; Bolds LN; Toole BP; Maria BL
Clin Cancer Res; 2008 Mar; 14(6):1804-13. PubMed ID: 18347183
[TBL] [Abstract][Full Text] [Related]
15. Restoration of stemness-high tumor cell-mediated suppression of murine dendritic cell activity and inhibition of tumor growth by low molecular weight oyster polysaccharide.
Zhong M; Zhong C; Hu P; Cui W; Wang G; Gao H; Liu C; Liu Z; Li Z; Li C; Gohda E
Int Immunopharmacol; 2018 Dec; 65():221-232. PubMed ID: 30321818
[TBL] [Abstract][Full Text] [Related]
16. Tumor doubling time and local immune response to hepatic metastases from colorectal cancer.
Kito A; Tanaka K; Fujimaki H; Nakazawa M; Togo S; Minami M; Shimada H
J Surg Oncol; 2007 Nov; 96(6):525-33. PubMed ID: 17654526
[TBL] [Abstract][Full Text] [Related]
17. Obovatol inhibits colorectal cancer growth by inhibiting tumor cell proliferation and inducing apoptosis.
Lee SK; Kim HN; Kang YR; Lee CW; Kim HM; Han DC; Shin J; Bae K; Kwon BM
Bioorg Med Chem; 2008 Sep; 16(18):8397-402. PubMed ID: 18762427
[TBL] [Abstract][Full Text] [Related]
18. mTOR signaling pathway is a target for the treatment of colorectal cancer.
Zhang YJ; Dai Q; Sun DF; Xiong H; Tian XQ; Gao FH; Xu MH; Chen GQ; Han ZG; Fang JY
Ann Surg Oncol; 2009 Sep; 16(9):2617-28. PubMed ID: 19517193
[TBL] [Abstract][Full Text] [Related]
19. Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin-17.
Fransen JH; Hilbrands LB; Ruben J; Stoffels M; Adema GJ; van der Vlag J; Berden JH
Arthritis Rheum; 2009 Aug; 60(8):2304-13. PubMed ID: 19644874
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
